Fenwick & West represented Nurix Therapeutics in the offering. Nurix Therapeutics, Inc. (NASDAQ: NRIX), a company developing targeted protein modulation drugs, executed its initial public offering…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now